Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLC (PET Boost)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by The Netherlands Cancer Institute
Sponsor:
Collaborators:
Maastricht Radiation Oncology
Maastricht University Medical Center
Artforce
GROW
Information provided by (Responsible Party):
The Netherlands Cancer Institute
ClinicalTrials.gov Identifier:
NCT01024829
First received: December 1, 2009
Last updated: March 27, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)